The present disclosure relates to a new type of vortioxetine analogue of Formula I or its polymorph or a solvate, a composition, and a kit comprising the analogue, the polymorph or the solvate, and the use of the compound or the polymorph or the solvate, or the composition in the preparation of a medicament for the treatment of depression. The methods of preparation of the analogues and intermediate compounds are also described.
本公开涉及一种新型的vortioxetine衍
生物,其
化学式为I或其多晶型或溶剂化物,以及包含该衍
生物、多晶型或溶剂化物的组合物和工具箱,以及该化合物、多晶型或溶剂化物或组合物在制备治疗抑郁症药物中的用途。还描述了衍
生物和中间化合物的制备方法。